1. A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. (January 2022) Authors: Plummer, Ruth; Dean, Emma; Arkenau, Hendrik-Tobias; Redfern, Charles; Spira, Alexander I.; Melear, Jason M.; Chung, Ki Y.; Ferrer-Playan, Jordi; Goddemeier, Thomas; Locatelli, Giuseppe; Dong, Jennifer; Fleuranceau-Morel, Patricia; Diaz-Padilla, Ivan; Shapiro, Geoffrey I. Journal: Lung cancer Issue: Volume 163(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours. (November 2016) Authors: Jamieson, David; Griffin, Melanie J.; Sludden, Julieann; Drew, Yvette; Cresti, Nicola; Swales, Karen; Merriman, Mark; Allen, Rodger; Bevan, Paul; Buerkle, Markus; Mala, Carola; Coyle, Vicky; Rodgers, Lisa; Dean, Emma; Greystoke, Alastair; Banerji, Udai; Wilson, Richard H.; Evans, T.R. Jeffery; An... Journal: European journal of cancer Issue: Volume 68(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial. Issue 1 (4th February 2019) Authors: Chung, Hyun Cheol; Arkenau, Hendrik-Tobias; Lee, Jeeyun; Rha, Sun Young; Oh, Do-Youn; Wyrwicz, Lucjan; Kang, Yoon-Koo; Lee, Keun-Wook; Infante, Jeffrey R.; Lee, Sung Sook; Kemeny, Margaret; Keilholz, Ulrich; Melichar, Bohuslav; Mita, Alain; Plummer, Ruth; Smith, Denis; Gelb, Arnold B.; Xiong, Hui... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRAF Wild-type, PTEN Mutant Malignant Uveal Melanoma Arising Within a Mature Ovarian Teratoma: A Case Report and Review of the Literature. (July 2020) Authors: Lengyel, Krisztina; Young, Fergus; Kucukmetin, Ali; Cresti, Nicola; Plummer, Ruth; Ralte, Angela; O'Donnell, Rachel Louise Journal: International journal of gynecological pathology Issue: Volume 39:Number 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chronic cardiovascular toxicity in the older oncology patient population. Issue 5 (September 2019) Authors: Findlay, Simon G.; Gill, Jason H.; Plummer, Ruth; DeSantis, Carol; Plummer, Chris Journal: Journal of geriatric oncology Issue: Volume 10:Issue 5(2019) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Issue 17 (23rd June 2022) Authors: Hollebecque, Antoine; Salvagni, Stefania; Plummer, Ruth; Niccoli, Patricia; Capdevila, Jaume; Curigliano, Giuseppe; Moreno, Victor; de Braud, Filippo; de Villambrosia, Sonia Gonzalez; Martin‐Romano, Patricia; Baudin, Eric; Arias, Marina; de Alvaro, Juan; Parra‐Palau, Josep L.; Sánchez‐Pérez, Tani... Journal: Cancer Issue: Volume 128:Issue 17(2022) Page Start: 3185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study. Issue 7 (23rd July 2021) Authors: Sanborn, Rachel E; Hamid, Omid; de Vries, Elisabeth GE; Ott, Patrick A; Garcia-Corbacho, Javier; Boni, Valentina; Bendell, Johanna; Autio, Karen A; Cho, Daniel C; Plummer, Ruth; Stroh, Mark; Lu, Lawrence; Thistlethwaite, Fiona Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. Issue 7 (6th July 2022) Authors: Bhave, Prachi; Ahmed, Tasnia; Lo, Serigne N; Shoushtari, Alexander; Zaremba, Anne; Versluis, Judith M; Mangana, Joanna; Weichenthal, Michael; Si, Lu; Lesimple, Thierry; Robert, Caroline; Trojanello, Claudia; Wicky, Alexandre; Heywood, Richard; Tran, Lena; Batty, Kathleen; Dimitriou, Florentia; St... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 7(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ipilimumab in the real world. Issue 5 (October 2015) Authors: Ahmad, Saif S.; Qian, Wendi; Ellis, Sarah; Mason, Elaine; Khattak, Muhammad A.; Gupta, Avinash; Shaw, Heather; Quinton, Amy; Kovarikova, Jarmila; Thillai, Kiruthikah; Rao, Ankit; Board, Ruth; Nobes, Jenny; Dalgleish, Angus; Grumett, Simon; Maraveyas, Anthony; Danson, Sarah; Talbot, Toby; Harries,... Journal: Melanoma research Issue: Volume 25:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients. Issue 5 (October 2015) Authors: Ahmad, Saif S.; Qian, Wendi; Ellis, Sarah; Mason, Elaine; Khattak, Muhammad A.; Gupta, Avinash; Shaw, Heather; Quinton, Amy; Kovarikova, Jarmila; Thillai, Kiruthikah; Rao, Ankit; Board, Ruth; Nobes, Jenny; Dalgleish, Angus; Grumett, Simon; Maraveyas, Anthony; Danson, Sarah; Talbot, Toby; Harries,... Journal: Melanoma research Issue: Volume 25:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗